Featured Content
European Biotech Targeting Anti-ageing
Oct 2nd 2024
Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Latest Videos
Latest News
CN Bio and LifeNet Health LifeSciences Partner to Supply Pre-Validated Cells
September 20th 2023
CN Bio and LifeNet Health LifeSciences have teamed up to provide direct access to a portfolio of highly characterized hepatic cells for the creation of advanced liver-on-a-chip assays.
Illumina Establishes New Center in India to Expand Genomics Capabilities
September 7th 2023
Illumina’s new solutions center in Bengaluru, India, will expand access to genomics in the country.
Bristol Myers Squibb Joins Cellares Program Focused on Automated Cell Therapy Manufacturing as Cellares is Launched as First IDMO
August 31st 2023
Bristol Myers Squibb has joined Cellares’ Technology Adoption Partnership program just as Cellares launches operations as an integrated development and manufacturing organization.
Three-Way Collaboration Between Rentschler Biopharma, CGT Catapult, and Refeyn Aims to Improve PAT for Gene Therapy Manufacturing
August 29th 2023
Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.
Danaher to Acquire Abcam in $5.7 Billion Deal
August 29th 2023
Danaher intends to acquire Abcam, a provider of life sciences assays and reagents, for $5.7 billion.
Royalty Pharma Places $500 Million Bet on Ferring Gene Therapy
August 24th 2023
Royalty Pharma agreed to spend up to $500 million for a 5.1 to 8% royalty on net sales of Ferring’s gene therapy adstiladrin (nadofaragene firadenovec-vcng).
Capstone Health Alliance and Bright Path Laboratories Enter Drug Shortage Agreement
August 24th 2023
Bright Path will develop and produce APIs for hospitals facing drug shortages in the Capstone Health Alliance.
Revive Therapeutics Announces Initiation of New Bucillamine Formulation Development
August 24th 2023
The formulation will be used to mitigate emerging infectious diseases and public health emergencies.
LEO Pharma to Acquire Timber Pharmaceuticals
August 22nd 2023
The deal is worth up to $36 million with an initial upfront consideration of $14 million, with an additional $22 million in contingent value rights (CVRs) that is payable upon achieving certain milestones.
Absci and Caltech Collaborate to Accelerate Affordable HIV Therapeutic Vaccine
August 17th 2023
A major grant from the Bill & Melinda Gates Foundation will bolster efforts to fight the global HIV/AIDS epidemic.